ライフサイエンスコーパス: genetic therapy

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 akes the hammerhead ribozyme a candidate for genetic therapy.

2 nd types of genetic cargo to develop diverse genetic therapies.

3 oach might lead to new types of vaccines and genetic therapies.

4 chnology could be applied to a wide range of genetic therapies.

5 help to enhance the efficacy of virus-based genetic therapies.

6 s on the current advances and limitations in genetic therapies against HIV, including the status of s

7 Ribozymes are promising genetic therapy agents and should, in the future, play a

8 Skin is an attractive target for delivery of genetic therapies and vaccines.

9 ein and peptide therapy, cell-based therapy, genetic therapy, application of scaffolds, bone anabolic

10 In recent years, genetic therapy approaches have been explored in preclin

11 Although genetic therapies are maturing as the rules of bioenerge

12 Directed cytokine and genetic therapies are on the horizon.

13 The genetic therapy as well as treatment with dendrimer alon

14 of human multistep carcinogenesis, validated genetic therapy by 3-phosphoinositide-dependent protein

15 Drug and genetic therapies can now be tested in this mouse model

16 beta-thalassemia, raising the potential for genetic therapy directed at enhancing HbF.

17 During the past 10years, genetic therapy directed toward correction of RNA mis-sp

18 The genetic therapy exploited a truncated HIF-1alpha protein

19 the feasibility of targeting platelets with genetic therapies for better management of patients with

20 cell development and for the development of genetic therapies for diseases involving hematopoietic c

21 luence the coagulation system, the future of genetic therapies for hemostasis is bright.

22 stem will prove useful for the evaluation of genetic therapies for hFVIII immunomodulation and bring

23 rapies for hFVIII immunomodulation and bring genetic therapies for hFVIII tolerance closer to clinica

24 asis in disease, and testing of cellular and genetic therapies for the correction of thalassemia.

25 es could have implications for the design of genetic therapies for treatment of Fanconi anemia and po

26 egulatory protein Rev has been explored as a genetic therapy for AIDS.

27 n future studies concerning the potential of genetic therapy for DMD, as well as other muscle disorde

28 r and expression suggests the feasibility of genetic therapy for retinal disease.

29 The main obstacle to genetic therapies has been the development of vectors ab

30 Genetic therapies have attempted introduction of nucleic

31 and myotonic dystrophy (DM), but attempts at genetic therapy have yet to prove successful.

32 nant retroviral vectors to effect corrective genetic therapies in hematopoietic stem cells (HSCs) has

33 n, will be crucial for the future success of genetic therapies in the brain.

34 s not harmful and allowing possibilities for genetic therapy interventions that utilize overexpressio

35 Genetic therapy is undergoing a renaissance with expansi

36 riction endonucleases are feasible tools for genetic therapy of a sub-group of mitochondrial disorder

37 Lessons learned from systemic genetic therapy of muscle disorders also should have imp

38 Genetic therapies, particularly adeno-associated viruses

39 The systemic delivery of genetic therapies required for the treatment of inaccess

40 Based on these results, genetic therapies targeted towards selective manipulatio

41 eroid treatment improves outcomes and on new genetic therapies that require early diagnosis for effec

42 c basis of the syndromes is hoped to lead to genetic therapy that can restore repolarisation.

43 hold promise for the clinical application of genetic therapies to combat AIDS.

44 n to develop persistent, effective non-viral genetic therapies to treat this condition.

45 Current strategies for genetic therapy using Moloney retroviruses require ex vi

46 harnessed for the targeted delivery of human genetic therapies via the introduction of exogenous gene

47 ealth care and the increasing feasibility of genetic therapy will, although slowly, augment the futur

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。